Alluvi tirzepatide is emerged as a promising therapeutic candidate for the management of metabolic diseases. This initial evaluation explored the efficacy and tolerability of tirzepatide 40mg in experimental models of type 2 diabetes. The research demonstrated that tirzepatide 40mg substantially improved glycemic control and lowered insulin resista